Skip to main content

Table 1 Admission characteristics and subsequent outcomes

From: Clinical impact of screening computed tomography in extracorporeal membrane oxygenation: a retrospective cohort study

Variable

Total cohort (N = 761)

Demographics

 

Age, years

45 (34–53)

Male sex, n(%)

449 (59)

Body mass index (kg/m2)

27.78 (24.2–33.6)

Clinical parameters

 

APACHE II score

17 (14–21)

Peak pressure (cmH2O)

22 (20–27)

Positive end expiratory pressure (cmH2O)

10 (10–10)

Dynamic compliance (ml/cmH2O)

12.5 (5.6–21)

Heart rate (BPM)

97 (82–112.5)

Mean arterial pressure (mmHg)

80 (70–90)

Lactate (mmol/L)

1.95 (1.3–3.7)

Haemoglobin (g/L)

98 (87–112)

Platelets (× 109/L)

180.5 (106.5–256)

International normalized ratio

1.1 (1–1.2)

Bilirubin (µmol/l)

13 (8–23)

Creatinine (µmol/l)

110.5 (64–192.75)

C-reactive protein (mg/L)

200 (87–315)

Diagnostic category

 

Asthma, n(%)

41 (5.4)

Extrapulmonary ARDS, n(%)

54 (7.1)

Non-infectious pulmonary ARDS, n(%)

50 (6.6)

 Pulmonary vasculitis

22 (2.9)

 Inflammatory or interstitial lung disease

28 (3.7)

Infectious pulmonary ARDS, n(%)

532 (69.9)

 Pneumonia (aspiration)

37 (4.9)

 Pneumonia (bacterial)

222 (29.2)

 Pneumonia (viral)

273 (35.9)

Other, n(%)

84 (11.0)

 Trauma

25 (3.3)

 Inhalation injury

8 (10.5)

 Obstetrics

3 (0.4)

 Pulmonary Embolism

7 (0.9)

 Other diagnoses

41 (5.4)

Outcome

 

ECMO ICU Length of stay (days)

19 (12–31)

ECMO ICU Mortality, n(%)

144 (18.9)

  1. All data presented as median (interquartile range) or n(%) if specified
  2. APACHE Acute Physiology and Chronic Healthy Evaluation, ECMO ICU Extracorporeal Membrane Oxygenation Intensive Care Unit